🔓
Sign in as a Member to unlock the full view of EDIT. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
EDIT

Editas Medicine, Inc.

Sector: healthcareBiotechnologyNASDAQMarket Cap: $174.7M

Minimal political surface area biotech with zero lobbying, government contracts, insider activity, or recent congressional trades.

Next filing → your inbox
Govt Dependence
0/100
Regulatory Density
70/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat EDIT does

Editas Medicine, Inc. (EDIT) is a biotechnology company in the healthcare sector.

12 months past · 3 months futureEDIT activity timeline

$4$3$2 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $3.75 hi $1.67 lo $1.87 CONGRESS 30 INSIDERS 0 13F FUNDS 30 BILLS 30 Renaissance Technologies · + $10M · 2026-03-31Renaissance Technologies · - $8M · 2026-06-30Renaissance Technologies · holds $6M · 2026-09-30Renaissance Technologies · + $6M · 2025-12-31D.E. Shaw & Co. · holds $6M · 2026-06-30AQR Capital Management · + $5M · 2026-06-30D.E. Shaw & Co. · + $5M · 2026-03-31Two Sigma Investments · - $4M · 2026-06-30Two Sigma Investments · - $4M · 2026-03-31AQR Capital Management · OPENED $3M · 2026-03-31Two Sigma Investments · holds $3M · 2025-12-31Citadel Advisors · + $2M · 2026-03-31Citadel Advisors · - $1M · 2026-06-30Citadel Advisors · + $1M · 2025-12-31 HR.161 · floor · 2026-04-28HR.184 · reported · 2026-09-15HR.178 · reported · 2026-01-08HR.109 · committee · 2025-12-19 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
250 trading days · 0 congressional trades shown · 0 insider buys · 14 13F filings · 4 past bill actions · 5 upcoming markups

Lifetime Government AwardsEDIT federal contracts

EDIT doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding EDIT

$23.9M
Total EDIT held by tracked 13F funds
6
Funds with EDIT positions
Renaissance Technologies $6M holds 2026-09-30
D.E. Shaw & Co. $6M holds 2026-06-30
AQR Capital Management $5M +15% 2026-06-30
Two Sigma Investments $4M -14% 2026-06-30
Citadel Advisors $1M -48% 2026-06-30
Point72 Asset Management $406K +7% 2026-06-30

Congressional TradesWho in Congress is trading EDIT

2023-04-10 Daniel S. Goldman D-New York · house sale $1,001 - $15,000
2023-04-10 Daniel S. Goldman D-New York · house Sale $1,001 - $15,000
2021-04-14 Donald S. Beyer D-Virginia · house sale $1,001 - $15,000
2021-04-14 Donald S. Beyer D-Virginia · house Sale $1,001 - $15,000
2021-03-02 Donald S. Beyer D-Virginia · house sale $1,001 - $15,000
2021-03-02 Donald S. Beyer D-Virginia · house Sale $1,001 - $15,000
2020-11-17 Donald S. Beyer D-Virginia · house purchase $1,001 - $15,000
2020-11-17 Donald S. Beyer D-Virginia · house Purchase $1,001 - $15,000
2020-05-01 Donald S. Beyer D-Virginia · house sale $1,001 - $15,000
2020-05-01 Donald S. Beyer D-Virginia · house Sale $1,001 - $15,000
2020-04-27 Donald S. Beyer D-Virginia · house sale $1,001 - $15,000
2020-04-27 Donald S. Beyer D-Virginia · house Sale $1,001 - $15,000
30+ trades on file · most recent 2023-05-19

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

2
stock awards · $153K market value
2026-11-05 O'Neill Gilmore Neil CEO AWARD 43,567 sh $111K
2026-11-05 Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER AWARD 16,533 sh $42K
For EDIT, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting EDITLive legislation impacting this stock

Political ProfileWhere EDIT sits in Washington

No lobbying spend, donations, or influence patterns per get_political_influence (score 0). No recent congressional trades per get_sector_political_positioning (0 buys/sells since 2024-04-29).

Member intelligence layer

Live signals + predictions for EDIT — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout EDIT & political exposure

Does Editas Medicine, Inc. (EDIT) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Editas Medicine, Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded EDIT stock?
32 congressional trades by 4 unique members of Congress, most recently on 2023-04-10. See the Congressional Trading panel for politician-by-politician breakdown.
What is EDIT political risk profile?
Government dependence: 0/100. Lobbying intensity: 0/100. Political signal: neutral.
How does GovGreed track EDIT political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. EDIT data is updated daily from these official federal sources.